Dr. Öğr. Üyesi GAMZE VARAN

Yayın Ağı

Makaleler 27

1. DENGUE VIRUS: EPIDEMIOLOGY, BIOLOGY AND CHALLENGES OF VACCINE DEVELOPMENT

Türegün Atasoy B., AYDIN S., VARAN G., DURUSU TANRIÖVER M.

journal of one health research , cilt.3, sa.1, ss.1-11, 2025 (Hakemli Dergi)

2. Optimization and characterization of Rituximab targeted multidrug loaded cyclodextrin nanoparticles against Non-Hodgkin Lymphoma

Demirturk N., VARAN G., KAĞA S., Malanga M., BİLENSOY E.

INTERNATIONAL JOURNAL OF PHARMACEUTICS , cilt.662, 2024 (SCI-Expanded, Scopus)

3. Folate Receptor β (FRβ) Expression on Myeloid Cells and the Impact of Reticuloendothelial System on Folate-Functionalized Nanoparticles' Biodistribution in Cancer

Goksen S., Varan G., Bilensoy E., Esendagli G.

MOLECULAR PHARMACEUTICS , sa.9, ss.4688-4699, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

4. In vitro and ex vivo evaluation of chitosan gel containing metformin-loaded polymeric nanoparticles for topical treatment of melanoma

Eke Z., Orgul D., VARAN G., ERDOĞDU N.

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , sa.7, ss.593-604, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

5. Influenza/B Yamagata Strain and Influenza Vaccines

SOYDAM S., VARAN G., ÜNAL S.

FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , cilt.29, sa.2, ss.165-171, 2024 (ESCI, TRDizin)

6. Cyclodextrin in Vaccines: Enhancing Efficacy and Stability

VARAN G.

FUTURE PHARMACOLOGY , sa.3, ss.597-611, 2023 (ESCI)

7. Three-Dimensional Cell Culture Methods in Infectious Diseases and Vaccine Research

Varan G., Unal S.

Future Pharmacology , cilt.3, sa.1, ss.48-60, 2023 (Hakemli Dergi) Sürdürülebilir Kalkınma

8. Insight into oral amphiphilic cyclodextrin nanoparticles for colorectal cancer: comprehensive mathematical model of drug release kinetic studies and antitumoral efficacy in 3D spheroid colon tumors

ÜNAL S., VARAN G., Benito J. M., AKTAŞ Y., BİLENSOY E.

Beilstein Journal of Organic Chemistry , cilt.19, ss.139-157, 2023 (SCI-Expanded, Scopus)

9. Synergistic Antitumor Potency of a Self-Assembling Cyclodextrin Nanoplex for the Co-Delivery of 5-Fluorouracil and Interleukin-2 in the Treatment of Colorectal Cancer

Akkın S., Varan G., Işık A., Gökşen S., Karakoç E., Malanga M., et al.

PHARMACEUTICS , cilt.15, sa.2, ss.1-23, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

10. A different approach to immunochemotherapy for colon Cancer: Development of nanoplexes of cyclodextrins and Interleukin-2 loaded with 5-FU

Akkin S., VARAN G., AKSÜT D., Malanga M., ERCAN A., ŞEN M., et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS , cilt.623, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

11. COVID-19 Vaccine Development Studies and Nanotechnology Approaches

VARAN G., AYDIN DİLSİZ S., ÜNAL S.

FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , sa.4, ss.519-526, 2022 (ESCI, TRDizin)

12. Peptide Based Vaccine Strategies

AYDIN S., VARAN G., ÜNAL S.

FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , cilt.27, sa.2, ss.189-195, 2022 (ESCI, TRDizin)

13. A Review on Cancer Immunotherapy and Applications of Nanotechnology to Chemoimmunotherapy of Different Cancers

Akkin S., VARAN G., BİLENSOY E.

MOLECULES , cilt.26, sa.11, 2021 (SCI-Expanded, Scopus)

14. Erlotinib entrapped in cholesterol-depleting cyclodextrin nanoparticles shows improved antitumoral efficacy in 3D spheroid tumors of the lung and the liver

Varan G., Demirturk N., Benito J. M., BİLENSOY E.

Journal of Drug Targeting , cilt.29, sa.4, ss.439-453, 2021 (SCI-Expanded, Scopus)

15. Polycationic cyclodextrin nanoparticles induce apoptosis and affect antitumoral activity in HepG2 cell line: An evaluation at the molecular level

ERCAN A., ÇELEBİER M., ÖNCÜL S., VARAN G., KOÇAK E., Benito J. M., et al.

International Journal of Pharmaceutics , cilt.598, 2021 (SCI-Expanded, Scopus)

16. Therapeutic efficacy and biodistribution of paclitaxel-bound amphiphilic cyclodextrin nanoparticles: Analyses in 3D tumor culture and tumor-bearing animals in vivo

Varan G., Varan C., Öztürk S. C., Benito J. M., Esendağlı G., Bilensoy E.

Nanomaterials , cilt.11, sa.2, ss.1-18, 2021 (SCI-Expanded, Scopus)

17. Erlotinib complexation with randomly methylated beta-cyclodextrin improves drug solubility, intestinal permeability, and therapeutic efficacy in non-small cell lung cancer

Erdogar N., Akkin S., VARAN G., BİLENSOY E.

PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY , cilt.26, ss.797-806, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

18. Cyclodextrin-Based Nanosystems: Current Status and Future Prospects

VARAN C., Varan G., Erdogar N., BİLENSOY E.

DRUG DELIVERY NANOSYSTEMS: FROM BIOINSPIRATION AND BIOMIMETICS TO CLINICAL APPLICATIONS , ss.29-58, 2019 (SCI-Expanded)

19. Plant-Based Natural Polymeric Nanoparticles as Promising Carriers for Anticancer Therapeutics

Varan G., VARAN C., BİLENSOY E.

POLYMERIC NANOPARTICLES AS A PROMISING TOOL FOR ANTI-CANCER THERAPEUTICS , ss.293-318, 2019 (SCI-Expanded)

20. Global omics strategies to investigate the effect of cyclodextrin nanoparticles on MCF-7 breast cancer cells

ERCAN A., ÇELEBİER M., VARAN G., ÖNCÜL S., Nenni M., KAPLAN O., et al.

European Journal of Pharmaceutical Sciences , cilt.123, ss.377-386, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

21. Cellular interaction and tumoral penetration properties of cyclodextrin nanoparticles on 3D breast tumor model

Varan G., Patrulea V., Borchard G., BİLENSOY E.

Nanomaterials , cilt.8, sa.2, 2018 (SCI-Expanded, Scopus)

22. Cyclodextrin-based polymeric nanosystems

Erdogar N., Varan G., VARAN C., BİLENSOY E.

DRUG TARGETING AND STIMULI SENSITIVE DRUG DELIVERY SYSTEMS , ss.715-748, 2018 (SCI-Expanded)

23. Amphiphilic cyclodextrin nanoparticles

VARAN G., VARAN C., ERDOĞAR N., Hincal A. A., BİLENSOY E.

International Journal of Pharmaceutics , cilt.531, sa.2, ss.457-469, 2017 (SCI-Expanded, Scopus)

24. Amphiphilic cyclodextrin derivatives for targeted drug delivery to tumors

ERDOĞAR N., VARAN G., BİLENSOY E.

Current Topics in Medicinal Chemistry , cilt.17, sa.13, ss.1521-1528, 2017 (SCI-Expanded, Scopus)

25. Development of polycationic amphiphilic cyclodextrin nanoparticles for anticancer drug delivery

Varan G., Benito J. M., Mellet C. O., BİLENSOY E.

Beilstein Journal of Nanotechnology , cilt.8, sa.1, ss.1457-1468, 2017 (SCI-Expanded, Scopus)

26. Cholesterol-Targeted Anticancer and Apoptotic Effects of Anionic and Polycationic Amphiphilic Cyclodextrin Nanoparticles

VARAN G., ÖNCÜL S., ERCAN A., BENITO J. M., MELLET C. O., BİLENSOY E.

Journal of Pharmaceutical Sciences , cilt.105, sa.10, ss.3172-3182, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

27. Cationic polymer nanoparticles for drug and gene delivery

BİLENSOY E., Işik G., VARAN C.

RSC Polymer Chemistry Series , sa.13, ss.268-295, 2015 (SCI-Expanded)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 5

1. Development and Characterization of Erlotinib-Randomly Methylated-β-cyclodextrin Complex for the Treatment of Non-small Lung Cancer

ERDOĞDU N., Akkın S., VARAN G., BİLENSOY E.

13th Internation symposium of Pharmaceutical Science, Ankara, Türkiye, 22 - 25 Haziran 2021, (Tam Metin Bildiri)

2. A Metabolomic Study to Investigate the Effect of Folate Conjugated Nanoparticles on Triple Negative Breast Cancer Cells

ERCAN A., ÇELEBİER M., varol ı., KAPLAN O., Varan G., ÖNCÜL S., et al.

EUFEPS Annual Meeting 2019 PERSONALIZED MEDICINES,TARGETED THERAPIES,PRECISION DRUG DELIVERY, 6 - 08 Mart 2019, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

3. The effect of polycationic amphiphilic cyclodestrin nanoparticles on mda-mb cancer cells: A metabolomic approach to understand the mechanism

ÇELEBİER M., KAPLAN O., VARAN G., ÖNCÜL S., KOÇAK E., ERCAN A., et al.

12 th International symposium on pharmaceutical sciences, 26 Haziran 2018, (Özet Bildiri) Sürdürülebilir Kalkınma

4. GENOMIC AND METABOLOMIC STUDIES OF POLYCATIONIC AMPHIPHILIC CYCLODEXTRIN NANOPARTICLESON HEPG2 CELL LINE

ERCAN A., ÇELEBİER M., Varan G., ÖNCÜL S., KOÇAK E., KAPLAN O., et al.

EUFEPS Annual Meeting 2018 Crossing Barriers for Future Medicines, 24 - 26 Mayıs 2018, (Tam Metin Bildiri)

5. Evaluation of Cholesterol-Targeted Amphiphilic Cyclodextrin Nanoparticles for Cancer Therapy

VARAN G., ÖNCÜL S., ERCAN A., BENİTO J., MELLET C. O., BİLENSOY E.

Innovation in Medicine Meetings III Congress, 11 - 13 Mayıs 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

Kitaplar 5

1. Folate receptor-mediated targeted breast cancer nanomedicine

Varan G., Varan C., Erdoğdu N., Bilensoy E.

Targeted Nanomedicine for Breast Cancer Therapy, Shivani Rai Paliwal,Rishi Paliwal, Editör, Academic Press , London, ss.153-169, 2022 Sürdürülebilir Kalkınma

2. Biodistribution of polymeric, polysaccharide and metallic nanoparticles

Erdoğdu N., Varan G., Varan C., Bilensoy E.

Characterization of Pharmaceutical Nano- and Microsystems, Peltonen Leena,Douroumis Dennis,Fahr Alfred,Siepmann Jurgen,Snowden Martin J., Editör, John Wiley & Sons, West Sussex, UK , Cambridge, ss.275-290, 2020

3. Cyclodextrin Based Nano-Systems: Current Status and Future Prospects

VARAN C., VARAN G., ERDOĞAR N., BİLENSOY E.

Drug Delivery Nanosystems: From Bioinspiration and Biomimetics to Clinical Applications, Pippa Natassa, Demetzos Costas, Pispas Stergios, Editör, Pan Stanford, ss.29-49, 2019

4. Plant based natural polymer (Guar gum, pectin, starch, cellulose, cyclodextrins) nanoparticles as promising tool for anticancer therapeutics

VARAN G., VARAN C., BİLENSOY E.

Polymeric Nanoparticles as a Promising Tool for Anti-cancer Therapeutics, Prashant Kesharwani, Kishore M. Paknikar, Virendra Gajbhiye, Editör, Academic Press, 2019 Sürdürülebilir Kalkınma

5. Cyclodextrin-based polymeric nanosystems

ERDOĞAR N., VARAN G., VARAN C., BİLENSOY E.

Drug Targeting and Stimuli Sensitive Drug Delivery Systems, Alina M. Holban, Editör, William Andrew, ss.715-748, 2018

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

232

H-İndeks (WoS)

Atıf (Scopus)

229

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Proje

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler